Author

Robin L. Jones

Institute of Cancer ResearchORCID 0000-0003-4173-3844Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Khin ThwayiD· 2 shared Amani Arthur· 1 shared Anguraj SadanandamiD· 1 shared Atiya MansooriD· 1 shared Brian S. HernandeziD· 1 shared Carol J. BultiD· 1 shared Charles KelleriD· 1 shared Christopher P. Wilding· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Khin ThwayORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivNov 18, 2023

Proteomic Features of Adolescents and Young Adults with Soft Tissue Tumours

Yuen Bun Tam, Kaan Low, Hari PS…·Paul H. Huang

This study compares proteomic profiles of adolescents and young adults with soft tissue tumours to older adults, identifying age-specific molecular features and potential therapeutic targets.

DOI 10.1038/s43856-024-00522-x

humanproteomics

𝕏 PostBluesky

BioinformaticsBMC CancerPeer-reviewedJun 17, 2019

Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma

Noah Berlow, Rishi Raj Rikhi, Mathew N. Geltzeiler…·Charles Keller

This paper develops a probabilistic model integrating sequencing and functional assay data to predict personalized drug combinations for sarcoma patients with exhausted treatment options.

21 citations

mousebulk RNA-seq

𝕏 PostBluesky